Charles Grinstead
Overland Park,Kansas
Summary
Experienced senior law enforcement professional with a proven track record in leadership and strategic planning. Excellent inter-personal and problem-solving skills. Possess a strong criminal investigative foundation to effectively supervise, support, and motivate teams to accomplish goals of the organization.
Overview
29
29
years of professional experience
Work History
Special Agent in Charge
FDA – Office of Criminal Investigations Kansas City Field Office
08.2018 - Current
- Expertise in managing and conducting criminal investigations of the Federal Food, Drug, and Cosmetic Act
- Subject matter competency with FDA-Office of Criminal Investigations policies, procedures, and objectives
- Manages criminal investigation activities for a multi-state (eleven states) jurisdictional scope of work
- Formulates short- and long-term work plans, objectives, and adjusts staff and resources as necessary
- Monitors and controls assets in support of criminal investigative operations including equipment and supplies
- Develops, justifies, and oversees the Field Office budget for optimum utilization of investigative mission
- Monitors progress of all assigned criminal investigations with regular contact and communication with subordinates, supervisors/team leaders and staff
- Maintains effective working relationships with all federal, state, and local law enforcement agencies as well as the Department of Justice entities
- Participates with top level management in determining program goals and resource allocation
- Provides technical and administrative direction for four subordinate managers performing the work and functions of the organization
- Identifies strategic objectives and obtains resources to execute goals
- Facilities defining of roles and work requirements, hires employees and assigns supervisors to achieve results teams
- Recommends employee promotions, recognitions, and awards
- Implements performance modifications and takes corrective actions as appropriate
- Provides equal opportunity in all federal human capital and employment programs
Assistant Special Agent in Charge
FDA-Office of Criminal Investigations – Kansas City Field Office
08.2014 - 08.2018
- Provided effective counsel, motivation, and leadership to criminal investigators and administrative staff to achieve goals set forth in FDA-OCI’s strategic priorities
- Recognized for expertise in conducting criminal investigations in regard to the Food, Drug, and Cosmetic Act and related federal violations of Title18 United States Code
- Collaborated with private sector organizations, state regulatory agencies, federal and state law enforcement to further FDA’s public health mission
- Directed and effectively supervised complex investigations involving federal prosecution of defendants and seizure of illegally obtained assets
- Contributed technical and administrative supervision for criminal investigators and administrative staff to achieve work priorities, evaluations, and goals
- Prepared and approved Performance Management Appraisal Program for administrative and investigative personnel
- Managed, monitored, and directed assets in support of investigative operations including equipment, personnel, and supplies for our team
- Coordinated with the Special Agent in Charge and the other Assistant Special Agent in Charge to create and finalize office objectives
- Represented FDA-OCI at the National Association of Drug Diversion Investigators (NADDI) regional event
- Invited to participate and speak at the2018 NADDI National Event
- Collaborated with other OCI-KCK agents to create a “Drug Tampering in Healthcare Facilities” brochure for educational purposes which was distributed to FDA-OCI agents throughout the country
Special Agent/Criminal Investigator
FDA- Office of Criminal Investigations
05.2004 - 07.2014
- Conducted complex criminal investigations of alleged or suspected violations of criminal laws to include all statutes enforced by the FDA: The Food, Drug, and Cosmetic Act, Federal Anti-Tampering Act, Prescription Drug Marketing Act, and the Safe Medical Device Act
- Identified and investigated cases based on OCI priorities, policies, and procedures
- Coordinate investigations with federal, state, and local stakeholders
- Interviewed and interrogated suspects, created and submitted surveillance, search, and arrest operational plans, and collected/preserved evidence
- Analyzed financial data evidence and prepared asset forfeiture requests
- Researched and identified the facts supporting evidence, presented to the United States Attorney’s office and testified at judicial proceedings
Special Agent/Criminal Investigator
United States Secret Service
04.1996 - 05.2004
- Vice President’s Detail – Washington DC - May2002-2004 – OPERATIONS AGENT Coordinated and managed the scheduling of twenty (20) US Secret Service Agents for the transportation section of the Vice President and family; Researched, planned, and implemented Vice Presidential motorcade routes; Organized security site plans for Vice Presidential visits throughout the United States
- Rated “Exceptional” upon departure
- Criminal Investigator – Kansas City and Springfield, Missouri – Executed complex and sensitive investigations which included bank fraud, identity fraud, counterfeit currency, and threats against assigned protected individuals of the US Secret Service
- Case agent (2001) – Suppression of one of the largest domestic counterfeit plant operations within the last ten (10) years
- Acting Resident Agent in Charge (2001) of the Springfield, Missouri Office: managed and supervised staff
- Case agent (1997) – Successful prosecution of a former Assistant United States Attorney involving the handling of an informant and undercover operations
Education
Master’s in Public Administration (MPA) -
St. Louis University
05.1994
Bachelor of Arts - Political Science/Sociology
Drake University
05.1991
Skills
- Excellent communication skills
- Ability to motivate others
- Diplomatic and good listener
- Leadership acumen
- Trustworthy and Dedicated
- Organized and Self Motivated
Accomplishments
- 2013 - Director of Excellence Award – Co- Case agent in a complex international investigation of counterfeit cancer prescription drug
- 2012-2014 – Indictment of two Canadian nationals operating a Canadian company distributing counterfeit unapproved new drugs
- 2012 – Successful felony prosecution of an adulterated food investigation in Albuquerque, New Mexico
- 2012 – Successful felony prosecution of an Arkansas store owner selling dietary supplements containing steroids causing major health problems
- 2012 – Successful federal prosecution of a large United States pharmaceutical manufacturing company and the Chief Executive Officer
- 2007-2009 – Successful conviction of two individuals in the importation of contaminated pet food resulting in thousands of animal deaths in the United States
- 2007-2009 – First successful prosecution of an illegal internet pharmaceutical operation in US District Court - Eastern District of Missouri.
- Successful2004 to2014 – Co-Case Agent – One of the largest counterfeit drug distributions in OCI history to date (four million doses) distributed. Successful prosecution of ten (10) defendants.
Timeline
Special Agent in Charge
FDA – Office of Criminal Investigations Kansas City Field Office
08.2018 - Current
Assistant Special Agent in Charge
FDA-Office of Criminal Investigations – Kansas City Field Office
08.2014 - 08.2018
Special Agent/Criminal Investigator
FDA- Office of Criminal Investigations
05.2004 - 07.2014
Special Agent/Criminal Investigator
United States Secret Service
04.1996 - 05.2004
Bachelor of Arts - Political Science/Sociology
Drake University
Master’s in Public Administration (MPA) -
St. Louis University
Similar Profiles
Megan Grace MangelMegan Grace Mangel
Detective at Criminal Investigations Division, St Lucie County Sheriff’s OfficeDetective at Criminal Investigations Division, St Lucie County Sheriff’s Office
Jose Juan GalvezJose Juan Galvez
Deputy Director at Office of Strategic Programs (OSP) / Center for Drug Evaluation and Research (CDER) / Food and Drug Administration (FDA)Deputy Director at Office of Strategic Programs (OSP) / Center for Drug Evaluation and Research (CDER) / Food and Drug Administration (FDA)
Lauren Elizabeth AcheyLauren Elizabeth Achey
Student Trainee at FDA, Office Of Planning, Evaluation, And Risk ManaStudent Trainee at FDA, Office Of Planning, Evaluation, And Risk Mana